US · Healthcare

GB Sciences Inc (GBLX)

Biotechnology

GB Sciences Inc (GBLX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GBLX

P/E ratio

18.00

GB Sciences Inc (GBLX) — FAQ

What is GBLX's P/E ratio?

The price-to-earnings (P/E) ratio for GB Sciences Inc (GBLX) is 18.00 (data as of 2026-03-24).

Does GB Sciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for GB Sciences Inc (GBLX). Check the MyAverix Finance app for the latest dividend data.

What sector is GB Sciences Inc in?

GB Sciences Inc (GBLX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GBLX listed on?

GBLX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)